2m 2m 2m 2m 2m 2m 2m
XBiotech (XBIT)
NASDAQ
$1.96-$0.03 (-1.51%)
Price as of Oct 22, 2026 7:30 PM EDT- $60.7MMarket Cap
- -20.08%1-Year Change
- BiotechnologyIndustry
XBiotech (XBIT)
$1.96-$0.03 (-1.51%)
XBIT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.99 | ||
Change | -$0.03 (-1.49%) | ||
Open | $2.04 | ||
High | $2.04 | ||
Low | $1.98 | ||
Previous Close | $2.02 | ||
Volume | 58,251 | ||
30-Day Average Volume | 58,193 | ||
1-Week Change | -7.87% | ||
1-Month Change | -8.72% | ||
1-Year Change | -20.08% | ||
3-Year Change | -47.28% | ||
5-Year Change | -85.78% | ||
Fundamentals | |||
Shares Outstanding | 30.5M | ||
Total Assets | $133.7M | ||
Market Cap | $60.7M | ||
Enterprise Value | -$48.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$6.7M | ||
Free Cash Flow | -$4.5M | ||
EBIT | -$6.7M | ||
EBITDA | -$6.4M | ||
Net Working Capital | $107.8M | ||
EPS | -$0.22 | ||
Enterprise Value/EBITDA | 8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -9 | ||
PEG | 0 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 07/15/2021 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield